Press Releases

DateTitleLink
November 9, 2021Aleta Biotherapeutics Announces ALETA-001 Presentation at 63rd ASH Annual MeetingVIEW PDF
October 1, 2021Aleta Biotherapeutics to Present at Society for Immunotherapy of CancerVIEW PDF
June 23, 2021Aleta Biotherapeutics and Cancer Research UK collaborate to advance blood cancer therapy into the clinicVIEW PDF
June 21, 2021Paul Rennert, President & Chief Scientific Officer, Aleta Biotherapeutics will present a talk entitled “A Novel CAR therapy for Metastatic Breast Cancer” at the virtual Her2-Targeted Therapies Summit on Thursday June 24th. This live presentation is scheduled at 9:40am EST.VIEW AGENDA
June 21, 2021Paul Rennert, President & Chief Scientific Officer, Aleta Biotherapeutics will present a talk entitled “Fusion Proteins to Bridge CAR19 T Cells and Tumor Cells” at the virtual “Next Generation CAR & T Cell Therapies Conference” on Thursday June 24th. This recorded presentation is scheduled at 3:00 EST.VIEW AGENDA
September 1, 2020CAR T-Cell Optimization Starts in Production, Extends to TherapyVIEW ARTICLE
December 7, 2019Aleta Biotherapeutics Presents In Vivo Results of a Novel Therapeutic Designed to Reactivate CAR T Cells in Patients Who Relapse After CAR T TherapyVIEW PDF
December 2, 2019Aleta Biotherapeutics Announces Oral Presentation at the 61st American Society of Hematology Annual Meeting (ASH)VIEW PDF
September 5, 2019Aleta Biotherapeutics Announces Appointments to Board of DirectorsVIEW PDF

Media